References
- Juniper EF, Daniel EE, Roberts RS, etal. Improve-ment in airway responsiveness and asthma severity during pregnancy, a prospective study. Am Rev Respir Dis 1989;140:924–31
- Troisi RI, Speizer FR, Willet WC, et al. Meno-pause, postmenopausal estrogen preparations, and the risk of adult-onset asthma. AmJ Respir Grit Care Med 1995;152:1183–8
- Lieberman D, Kopernik G, Parath A, et al. Sub-clinical worsening of bronchial asthma during estrogen replacement therapy in asthmatic post-menopausal women. Maturitas 1995;21:153–7
- Beynon HLC, Garbett ND, Barnes PJ. Severe premenstrual exacerbations of asthma: effect of intramuscular progesterone. Lancet 1988;13:370–2
- Genazzani AR, Gambaccini M. Hormone replace-ment therapy: the perspectives for the 21st century. Maturitas 1999;32 (1):11–7
- Ettinger B, Friedman G, Bush T, et al. Reduced mortality associated with long-term postmeno-pausal estrogen therapy. Obstet Gynecol 1996;87: 6–12
- Lindsay R, Bush TL, Grady D, et al. Estrogen replacement in menopause.J Clin Endocrinol Metab 1996;81:3829–38
- Sullivan JM. Practical aspects of preventing and managing atherosclerotic disease in post-menopausalwomen. EurHeartJ1996;17(SuppID): 32–7
- Genazzani AR, Spinetti A, Gallo R, et al. Meno-pause and the central nervous system: intervention options. Maturitas 1999;32 (2):103–10
- CaHens A, Vaillant L, Lecomte P, et al. Does hormonal skin ageing exist? A study of the influ-ence of different hormone therapy regimens on the skin ofpostmenopausalwomen using non-invasive measurement techniques. Dermatology 1996;193: 289–94
- Guidelines for the Diagnosis and Management of Asthma. National Heart, Lung and Blood Institute, 1997
- Myers JR, Sherman CB. Should supplemental estrogens be used as steroid-sparing agents in asthmatic women? Chest 1994;106:318–9
- Senna G, Mezzelani P, Andri L. Bronchial asthma in women: peculiar aspects. Recenti Prog Med 1989; 80:366–71
- Enmark E, Gustafsso nJA. Oestrogen receptors— an overview. J Intern Med 1999;246(2):133–8
- Weinstein RE, Lobocki CA, Gravett S, et al. Decreased adrenal sex steroid levels in the absence of glucocorticoid suppression in postmenopausal asthmatic women. J Allergy Clin Immunol 1996; 97:1–8
- Carandente F, Angeli A, Candiani GB, et al. Rhythms in the ovulatory cycle. 3rd: cortisol and dehydroepiandrosterone sulfate (DHEA-S). Chronobiologia 1990;17: 209–17
- Klaiber EL, Broverman DM, Vogel W, et al. Estrogens and central nervous system function: electroencephalography, cognition and depression. In: Friedman RC, ed. Behaviour and Menstrual Cycle. New York: Marcel Dekker, 1982: 267–89
- Baumann G. Estrogens and the hypothalamo-pituitary-adrenal axis in man: evidence for normal feedback regulation by corticosteroids. J Clin Endo-crinol Metab 1983;57:1193–7
- Dunn PJ, Mahood CB, Speed JF, et al. Dehydro-epiandrosterone sulfate concentrations in asthmatic patients: pilot study. NZ Med J1984;97:805–8
- Castelo-Branco C, Martinez de Osaba MJ, Fortuny A, et al. Circulating hormone levels in menopausal women receiving different hormone replacement therapy regimens. J Reprod Med 1995;40:556–60
- SIowthska-SrzednickaJ,ZgliczynskiS,Chotkowska E, et al. Effects of transdermal 1713 estradiol combined with oral progestogen on lipids and lipoproteins in hypercholesterolaemic post-menopausal women. J Int Med 1993;234:447–51
- Barnes PJ, Pedersen S. Efficacy and safety ofinhaled corticosteroids in asthma. Am Rev Respir Dis 1993;148 (Suppl):1–26